Fundraising Fox
/Companies
Sign in

Instapath Inc.

YC W19

Houston, US · Founded 2017 · Delaware corporation · 6 employees · 4 known investors

Find your way into Instapath Inc.

Sign up to see every warm intro you have to Instapath Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Instapath Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.

BiotechDeep TechHealthtechMedical DevicesUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W19)

Instapath Inc. was founded in 2017 by Mei Wang, Quincy Brown, and David Tulman.

MWMei Wang
Mei WangCofounderMei Wang is co-founder and CEO of Instapath Inc.
QBQuincy Brown
Quincy BrownCo-founder · CRO
DTDavid Tulman
David TulmanCo-founder · Chief Clinical OfficerDavid Tulman holds a Ph.D. in Bioinnovation from Tulane University with research focused on microscopy for cancer diagnostics, and has prior experience as a clinical researcher and commercialization intern at the New Orleans BioInnovation Center. He is Chief Clinical Officer at Instapath, a medical device company developing digital pathology systems.
PL
Peter LawsonCTO2016–2019

Investors · 4

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Thomas Jamesreported

How we know: Y Combinator's founder network · Not right? Tell us

Venture Investment AssociatesreportedPeapack

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 1 round · 2019

▶$1.8MraisedSep 2019 · 20 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David TulmanExecutive Officer, Director
  • David TulmanExecutive Officer, Director
  • David TulmanExecutive Officer, Director
  • David TulmanExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$1.8M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 7

ClarapathClarapath develops SectionStar, an automated tissue sectioning system for histology laboratories that aims to improve slide quality, reduce turnaround time and lower costs. The company builds healthcare robotics for laboratory medicine and pathology workflows.
Spire HealthSpire Health provides continuous respiratory monitoring devices used by pulmonologists and patients to track lung disease. The company's sensors enable remote tracking of chronic respiratory conditions across the United States.
Shift LabsShift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.
mPATH HealthmPATH Health develops an SMS-based behavioral science platform that guides patients through cancer screening decisions and increases completion rates across lung, breast, and colorectal screening programs. The platform serves health systems and Federally Qualified Health Centers (FQHCs) to automate patient navigation at scale.
ZenflowZenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
X-ZellX-ZELL develops cryoimmunostaining platforms and multiplex panels for cytology laboratories, enabling extraction of multiple biomarkers from single tissue specimens while preserving samples for further testing. The company serves pathologists, oncologists, and diagnostic partners primarily in Southeast Asia with CE-marked, ISO 13485-certified reagents and workflow solutions.
BodyportBodyport develops an FDA-cleared cardiac scale that non-invasively measures hemodynamic biomarkers through a patient's feet to detect early signs of worsening heart failure in a home setting. The company's platform pairs this hardware with a proprietary algorithm called the Congestion Index and a software system that integrates with electronic health records to enable remote patient monitoring and clinical decision support for heart failure management.

Companies working in the same space as Instapath Inc..

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase II2021$1M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Legal entities · 1

corporate structure
Instapath Inc.

Frequently asked questions

What does Instapath Inc. do?
Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.
Who founded Instapath Inc.?
Instapath Inc. was founded by Mei Wang, Quincy Brown, David Tulman in 2017.
Who are Instapath Inc.'s investors?
Instapath Inc.'s investors include Draper Associates, Y Combinator, Thomas James, Venture Investment Associates.
How much funding has Instapath Inc. raised?
Instapath Inc. has disclosed $1.8M raised across 1 round.
Where is Instapath Inc. headquartered?
Instapath Inc. is headquartered in Houston, US.